LETTER TO THE EDITOR
Characteristics of Open Public Hearing Speakers of the Tobacco Products Scientific Advisory Committee meetings
Craig M. Cooper 1  
,  
Sam Jellison 1
,  
 
 
More details
Hide details
1
Oklahoma State University Center for Health Sciences, Tulsa, OK, United States
Publish date: 2018-11-02
Submission date: 2018-10-20
Acceptance date: 2018-10-31
 
Tob. Prev. Cessation 2018;4(November):35
KEYWORDS:
TOPICS:
CORRESPONDING AUTHOR:
Craig M. Cooper   
Oklahoma State University Center for Health Sciences, 1111 W 17th St., Tulsa, 74107 OK, United States
 
REFERENCES (3):
1. Office of the Commissioner. Consumer Updates - The Facts on the FDA’s New Tobacco Rule. https://www.fda.gov/ForConsume.... Accessed June 29, 2018.
2. Abola MV, Prasad V. Characteristics and Conflicts of Public Speakers at Meetings of the Oncologic Drugs Advisory Committee to the US Food and Drug Administration. JAMA Intern Med. 2016;176(3):389-391. doi:10.1001/jamainternmed.2015.7805
3. McCoy MS, Pagán O, Donohoe G, Kanter GP, Litman RS. Conflicts of Interest of Public Speakers at Meetings of the Anesthetic and Analgesic Drug Products Advisory Committee. JAMA Intern Med. 2018;178(7). doi:10.1001/jamainternmed.2018.1325
eISSN:2459-3087